BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 22095746)

  • 1. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging.
    de Ruiter MB; Reneman L; Boogerd W; Veltman DJ; Caan M; Douaud G; Lavini C; Linn SC; Boven E; van Dam FS; Schagen SB
    Hum Brain Mapp; 2012 Dec; 33(12):2971-83. PubMed ID: 22095746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy.
    Koppelmans V; de Groot M; de Ruiter MB; Boogerd W; Seynaeve C; Vernooij MW; Niessen WJ; Schagen SB; Breteler MM
    Hum Brain Mapp; 2014 Mar; 35(3):889-99. PubMed ID: 23281152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-related cognitive impairment in patients with breast cancer based on MRS and DTI analysis.
    Tong T; Lu H; Zong J; Lv Q; Chu X
    Breast Cancer; 2020 Sep; 27(5):893-902. PubMed ID: 32301096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type.
    Stouten-Kemperman MM; de Ruiter MB; Koppelmans V; Boogerd W; Reneman L; Schagen SB
    Brain Imaging Behav; 2015 Jun; 9(2):275-84. PubMed ID: 24858488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging in late-life depression: multimodal examination of network disruption.
    Sexton CE; Allan CL; Le Masurier M; McDermott LM; Kalu UG; Herrmann LL; Mäurer M; Bradley KM; Mackay CE; Ebmeier KP
    Arch Gen Psychiatry; 2012 Jul; 69(7):680-9. PubMed ID: 22752234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy.
    Inagaki M; Yoshikawa E; Matsuoka Y; Sugawara Y; Nakano T; Akechi T; Wada N; Imoto S; Murakami K; Uchitomi Y
    Cancer; 2007 Jan; 109(1):146-56. PubMed ID: 17131349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy.
    Koppelmans V; de Ruiter MB; van der Lijn F; Boogerd W; Seynaeve C; van der Lugt A; Vrooman H; Niessen WJ; Breteler MM; Schagen SB
    Breast Cancer Res Treat; 2012 Apr; 132(3):1099-106. PubMed ID: 22205140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced brain changes in breast cancer survivors: evaluation with multimodality magnetic resonance imaging.
    Feng Y; Zhang XD; Zheng G; Zhang LJ
    Brain Imaging Behav; 2019 Dec; 13(6):1799-1814. PubMed ID: 30937827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study.
    McDonald BC; Conroy SK; Ahles TA; West JD; Saykin AJ
    Breast Cancer Res Treat; 2010 Oct; 123(3):819-28. PubMed ID: 20690040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?
    Billiet T; Emsell L; Vandenbulcke M; Peeters R; Christiaens D; Leemans A; Van Hecke W; Smeets A; Amant F; Sunaert S; Deprez S
    Brain Imaging Behav; 2018 Feb; 12(1):64-77. PubMed ID: 28102529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain morphometric changes associated with childhood-onset systemic lupus erythematosus and neurocognitive deficit.
    Gitelman DR; Klein-Gitelman MS; Ying J; Sagcal-Gironella AC; Zelko F; Beebe DW; Difrancesco M; Parrish T; Hummel J; Beckwith T; Brunner HI
    Arthritis Rheum; 2013 Aug; 65(8):2190-200. PubMed ID: 23666759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study.
    Menning S; de Ruiter MB; Veltman DJ; Boogerd W; Oldenburg HSA; Reneman L; Schagen SB
    Brain Imaging Behav; 2018 Apr; 12(2):324-334. PubMed ID: 28290072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy.
    Brown MS; Stemmer SM; Simon JH; Stears JC; Jones RB; Cagnoni PJ; Sheeder JL
    AJNR Am J Neuroradiol; 1998 Feb; 19(2):217-21. PubMed ID: 9504468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of chemotherapy-induced brain structural alterations in breast cancer patients with generalized q-sampling MRI and graph theoretical analysis.
    Li TY; Chen VC; Yeh DC; Huang SL; Chen CN; Chai JW; Chen CC; Weng JC
    BMC Cancer; 2018 Dec; 18(1):1211. PubMed ID: 30514266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients.
    Blommaert J; Schroyen G; Vandenbulcke M; Radwan A; Smeets A; Peeters R; Sleurs C; Neven P; Wildiers H; Amant F; Sunaert S; Deprez S
    Hum Brain Mapp; 2019 Dec; 40(17):4994-5010. PubMed ID: 31436005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
    J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy.
    Ferguson RJ; McDonald BC; Saykin AJ; Ahles TA
    J Clin Oncol; 2007 Sep; 25(25):3866-70. PubMed ID: 17761972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Dysfunction and Neurophysiologic Mechanism of Breast Cancer Patients Undergoing Chemotherapy Based on Resting State Functional Magnetic Resonance Imaging.
    Bai X; Zheng J; Zhang B; Luo Y
    World Neurosurg; 2021 May; 149():406-412. PubMed ID: 33096278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter changes in patients with breast cancer treated with high-dose chemotherapy and autologous bone marrow support.
    Stemmer SM; Stears JC; Burton BS; Jones RB; Simon JH
    AJNR Am J Neuroradiol; 1994 Aug; 15(7):1267-73. PubMed ID: 7976937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escitalopram increased gray matter and white matter in a first-episode drug-naïve panic disorder patient within 6 weeks.
    Lai CH
    J Neuropsychiatry Clin Neurosci; 2012; 24(2):E23-4. PubMed ID: 22772685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.